Evidence map›Paper›PMID 37892514›Full record

Trial reportNutrients2023

Impact of a Nutrient Formulation on Longitudinal Myelination, Cognition, and Behavior from Birth to 2 Years: A Randomized Clinical Trial.

Nora Schneider, Mickaël Hartweg, Jonathan O'Regan, Jennifer Beauchemin, Leanne Redman, Daniel S Hsia, Pascal Steiner, Owen Carmichael, Viren D'Sa, Sean Deoni

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nora SchneiderBrain Health, Nestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., 1010 Lausanne, Switzerland.
Mickaël HartwegBiostatistics and Data Management, Clinical Research Unit, Nestlé Research, Société des Produits Nestlé S.A., Vers-chez-les-Blanc, 1000 Lausanne, Switzerland.ORCID 0000-0002-2228-9103
Jonathan O'ReganNestlé Development Centre Nutrition, Askeaton, Co., RH6 0PA Limerick, Ireland.
Jennifer BeaucheminAdvanced Baby Imaging Lab, Hasbro Children's Hospital, Providence, RI 02903, USA.
Leanne RedmanPennington Biomedical Research Center, Baton Rouge, LA 70808, USA.ORCID 0000-0002-7267-7374
Daniel S HsiaPennington Biomedical Research Center, Baton Rouge, LA 70808, USA.
Pascal SteinerBrain Health, Nestlé Institute of Health Sciences, Nestlé Research, Société des Produits Nestlé S.A., 1010 Lausanne, Switzerland.
Owen CarmichaelPennington Biomedical Research Center, Baton Rouge, LA 70808, USA.
Viren D'SaAdvanced Baby Imaging Lab, Hasbro Children's Hospital, Providence, RI 02903, USA.ORCID 0000-0002-3476-8419
Sean DeoniDepartment of Pediatrics, Brown University, Providence, RI 02903, USA.

Funding

Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI ROBERT A KESTERSON · 2005 to 2026
$26.5M
NIDDK NIH HHS P30 DK072476
6 · The paper itself

Abstract

Observation studies suggest differences in myelination in relation to differences in early life nutrition. This two-center randomized controlled trial investigates the effect of a 12-month nutritional intervention on longitudinal changes in myelination, cognition, and behavior. Eighty-one full-term, neurotypical infants were randomized into an investigational (N = 42) or a control group (N = 39), receiving higher versus lower levels of a blend of nutrients. Non-randomized breastfed infants (N = 108) served as a reference group. Main outcomes were myelination (MRI), neurodevelopment (Bayley-III), social-emotional development (ASQ:SE-2), infant and toddler behavior (IBQ-R and TBAQ), and infant sleep (BISQ) during the first 2 years of life. The full analysis set comprised N = 67 infants from the randomized groups, with 81 myelin-sensitive MRI sequences. Significantly higher myelination was observed in the investigational compared to the control group at 6, 12, 18, and 24 months of life, as well as significantly higher gray matter volume at 24 months, a reduced number of night awakenings at 6 months, increased day sleep at 12 months, and reduced social fearfulness at 24 months. The results suggest that brain development may be modifiable with brain- and age-relevant nutritional approaches in healthy infants and young children, which may be foundational for later learning outcomes.

Indexed as

Breast FeedingCognitionBrainChild DevelopmentChild, PreschoolFemaleHumansInfantMyelin SheathNutrientsNutrientsbrain developmentinfant nutritionMRImyelinationphospholipidssphingomyelin

Identifiers

PMID37892514
PMCPMC10610069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.